Categories Analysis, Other Industries, U.S. Markets News

US home sales slide for third consecutive month

Sales of existing homes in the US fell for the third consecutive month in June. A shortage in inventory and a rise in prices are said to be the reasons for the decline in the purchase of homes. According to the National Association of Realtors, the seasonally adjusted annual rate for home sales was 5.38 million in June. This reflected a drop of 0.6% versus the previous month. When compared to the same period a year ago, sales fell 2.2%.

The continued slowdown over the past three months points to several challenges in the housing market. The growth in employment and wages have boosted the demand for homes, but this increase in demand combined with a shortage of homes has led to price increases. Increases in mortgage rates have led to high costs for buying homes and the recent tax bill also reduced the benefits of owning homes.

However, during June, inventory rose by 0.5% to 1.95 million compared to a year ago. This increase, which was the first one seen in around three years, could perhaps be a sign that the shortage is ending. Economists are waiting to see if this increase will continue going forward or if it was merely a one-time occurrence. An increase in inventory would lead to an increase in buyers.

The median sales price for a previously-owned home increased 5.2% in June to $276,900 compared to last year. In the West, this rate was double, with the median sales price rising 10.2% to $417,400 from the previous year. The West region also saw a drop in sales during June. There needs to be an increase in first-time buyers for the housing market to gain strength.

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top